Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-043032
Filing Date
2004-09-02
Accepted
2004-09-02 15:14:58
Documents
1
Period of Report
2004-08-31

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bsf01663_bsf3le.html 4  
1 MAIN DOCUMENT DESCRIPTION bsf01663_bsf3le.xml 4 9309
  Complete submission text file 0001209191-04-043032.txt   11614
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Issuer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address ONE CAMBRIDGE CENTER CAMBRIDGE MA 02142 6172257054
GADICKE ANSBERT (Reporting) CIK: 0001134655 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 041013721

Mailing Address ONE CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address ONE CAMBRIDGE CENTER CAMBRIDGE MA 02142 6172257054
EVNIN LUKE (Reporting) CIK: 0001134657 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29889 | Film No.: 041013722